(A) Presence of fibrin | |||||||
---|---|---|---|---|---|---|---|
Days after treatment | tPA (n=44) | Standard therapy (n=41) | Statistical significance | ||||
Any intraocular fibrin: | |||||||
Before therapy | 100% | 100% | ns | ||||
1 | 59.1% | 95.1% | p=0.001 | ||||
2 | 59% | 90.3% | p=0.001 | ||||
14 | 11.4% | 29.3% | p=0.039 | ||||
90 | 0% | 2.4% | ns | ||||
Anterior chamber fibrin: | |||||||
Before therapy | 84.1% | 85.4% | ns | ||||
1 | 45.5% | 80.5% | p=0.0009 | ||||
2 | 43.2% | 78.0% | p=0.001 | ||||
14 | 2.3% | 9.8% | ns | ||||
90 | 0% | 0% | ns | ||||
IOL surface fibrin: | |||||||
Before therapy | 97.7% | 92.7% | ns | ||||
1 | nd | nd | nd | ||||
2 | 47.7% | 80.5% | p=0.000067 | ||||
14 | 9.1% | 24.4% | p=0.05 | ||||
90 | 0% | 2.4% | ns | ||||
(B) Rate of intraocular fibrin 1 and 14 days after treatment | |||||||
Days after treatment | tPA (n=44) | Standard therapy (n=41) | |||||
1 | 14 | 90 | 1 | 14 | 90 | ||
None | 40.9% | 93.2% | 100% | 4.9% | 75.6% | 97.6% | |
Mild | 31.8% | 6.8% | 0% | 46.3% | 24.4% | 2.4% | |
Moderate | 25% | 0% | 0% | 39% | 0% | 0% | |
Severe | 2.3% | 0% | 0% | 9.8% | 0% | 0% |
U test: day 1: p=0.00069; day 14: p=0.025; day 90: ns.
nd=not documented, ns=no significant difference.